Floatz logo

PRAVASTATIN

CHILD B

University Hospital, BordeauxSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the CHILD B cohort.

Asset / SponsorPhaseRating
Sorafenib
University Hospital, Bordeaux
Phase 2B

Same molecule, other indications

PRAVASTATIN is also rated in:

hyperlipidemiaDormant
BBB
Indicative ·
76 / 100
View asset →
lipodystrophyDormant
BBB
Indicative ·
76 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →